Table 6.
Treatment and responsiveness of recurrences
| Treatment | Complete remission | Partial remission | No remission |
|---|---|---|---|
| Therapeutic schemes that include plasmapheresis (n = 12) | 3/12 (25) | 5/12 (41.7) | 4/12 (33.3) |
| Plasmapheresis + rituximab (n = 8) | 3/8 (37.5) | 2/8 (25) | 3/8 (37.5) |
| Plasmapheresis alone (n = 2) | 0/2 (0) | 2/2 (100) | 0/2 (0) |
| Plasmapheresis + steroids (n = 1) | 0/1 (0) | 0/1 (0) | 1/1 (100) |
| Plasmapheresis + steroids + intravenous immunoglobulin (n = 1) | 0/1 (0) | 1/1 (100) | 0/1 (0) |
| Rituximab alone (n = 1) | 1/1 (100) | 0/1 (0) | 0/1 (0) |
| mTORi withdrawal (n = 1) | 0/1 (0) | 1/1 (100) | 0/1 (0) |
| Total of treated patients (n = 14) | 4/14 (28.6) | 6/14 (42.8) | 4/14 (28.6) |
| No treatment (n = 1) | 0/1 (0) | 0/1 (0) | 1/1 (100) |
| Total (n = 15) | 4/15 (26.7) | 6/15 (40) | 5/15 (33.3) |
Values are presented as n/N (%).